Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension

Joo Yun Jun1, Jasenka Zubcevic, Yanfei Qi

  • 1Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA.

Insights

Brain oxidative stress drives hypertension by disrupting vascular repair. Targeting mitochondrial reactive oxygen species in the brain normalized blood pressure and improved the balance of endothelial progenitor cells and inflammatory cells.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Cell Biology

Background:

  • Oxidative stress in the brain contributes to hypertension by increasing sympathetic drive, inflammation, and vascular dysfunction.
  • The precise mechanisms linking brain oxidative stress to impaired brain-vascular communication in hypertension remain unclear.

Purpose of the Study:

  • To investigate if mitochondrial reactive oxygen species in hypothalamic paraventricular nucleus drive hypertension via inflammatory cells (ICs) and endothelial progenitor cells (EPCs) imbalance.
  • To determine if targeting these mitochondrial reactive oxygen species can restore brain-vascular communication and attenuate hypertension.

Main Methods:

  • Utilized a rat model of chronic angiotensin II infusion to induce hypertension.
  • Administered mitochondrial-targeted antioxidants intracerebroventricularly or subcutaneously.
  • Assessed blood pressure, sympathetic drive, baroreflex gain, microglia activation, and bone marrow EPCs/ICs.
  • Employed retrograde neuronal tracing to map brain-bone marrow communication pathways.

Main Results:

  • Angiotensin II infusion elevated blood pressure, sympathetic drive, and paraventricular nucleus microglia activation.
  • A significant decrease in bone marrow EPCs and increase in ICs were observed, reducing the EPC/IC ratio.
  • Intracerebroventricular antioxidant treatment attenuated hypertension, reduced microglia activation, and normalized EPCs/ICs, while subcutaneous treatment did not.
  • Neuronal tracing confirmed direct brain-bone marrow communication pathways.

Conclusions:

  • Mitochondrial reactive oxygen species in the brain's cardioregulatory areas are a key driver of hypertension.
  • Targeting brain mitochondrial oxidative stress can normalize the bone marrow EPC/IC balance and ameliorate hypertension.
  • This highlights a critical brain-vascular communication axis in hypertension pathophysiology.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...